Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 3, 2000, Pages 1293-1298

  Rodriguez Moreno, Antonio ^a   López Garcia, Juan C ^a   Lerma, Juan ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC INHIBITION;

2-AMINO-5-PHOSPHONOVALERATE; ACTION POTENTIALS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZODIAZEPINES; BICUCULLINE; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; INDOLES; INTERNEURONS; ISOXAZOLES; KAINIC ACID; LIDOCAINE; MALEIMIDES; NAPHTHALENES; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; PROPIONATES; PROTEIN KINASE C; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, KAINIC ACID; RECEPTORS, PRESYNAPTIC; SIGNAL TRANSDUCTION; STAUROSPORINE; VIRULENCE FACTORS, BORDETELLA;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0033964944     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.97.3.1293     Document Type: Article

References (28)

1. Lerma, J. (1997) Neuron 19, 1155-1158.
2. Ben-Ari, Y. (1985) Neuroscience 14, 375-403.
3. Nadler, J. (1981) Life Sci. 29, 2031-2042.
4. Paternain, A. V., Morales, M. & Lerma, J. (1995) Neuron 14, 185-189.
5. Wilding, T. J. & Huettner. J. E. (1995) Mol. Pharmacol. 47, 582-587.
6. Rodriguez-Moreno, A., Herreras, O. & Lerma, J. (1997) Neuron 19, 893-901.
7. Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizari, A., Bath, C. P., Thomas, J., Sharps, E. F., Davies, C. H., Ornstein, P. L., et al. (1997) Nature (London) 389, 599-602.
8. Cossart, R. Esclapez, M., Hirsch, J. C., Bernard, C. & Ben-Ari, Y. (1998) Nat. Neurosci. 1, 470-478.
9. Frerking, M., Malenka, R. C. & Nicoll, R. A. (1998) Nat. Neurosci. 1, 479-486.
10. Rodriguez-Moreno, A. & Lerma, J. (1998) Neuron 20, 1211-1218.
11. Bureau, L. Bischoff, S., Heinemann, S. F. & Mulle, C. (1999) J. Neurosci. 15, 653-663.
12. Li, P., Wilding, T. J., Kim, S. J., Calejesan, A., Huettner, J. E. & Zhou, M. (1999) Nature (London) 397, 161-164.
13. Bushell, T., Jane, D. E., Tse, H-W. Watkins, J. C. Garthwaite, J. & Collingridge, G. L. (1996) Br. J. Pharmacol. 117, 1457-1462.
14. Herb, A., Burnashev, N., Werner, P., Sakmann, B., Wisden, W. & Seeburg, P. H. (1992) Neuron 8, 775-785.
15. Huettner, J. E. (1990) Neuron 5, 255-266.
16. Galarreta, M. & Hestrin, S. (1998) Nat. Neurosci. 1, 587-594.
17. Bahn, S., Volk, B. & Wisden, W. (1994) J. Neurosci. 14, 5525-5547.
18. Paternain, A. V., Herrera, M. T., Nieto, M. A. & Lerma, J. (2000) J. Neurosci., 20, 196-205.
19. Garthwaite, J. (1985) Br. J. Pharmacol. 85, 297-307.
20. Rodríguez-Moreno, A., Sistiaga, A., Lerma, J. & Sánchez-Prieto, J. (1998) Neuron 21, 1477-1486.
21. Paternain, A. V., Rodriguez-Moreno, A., Villarroel, A. & Lerma J. (1998) Neuropharmacology 37, 1249-1259.
22. Kullmann, D. M. & Asztely, F. (1998) Trends Neurosci. 21, 8-14.
23. Dzubay, J. A. & Jahr, C. E. (1999) J. Neurosci. 19, 5265-5274.
24. Min, M.-Y., Melyan, Z. & Kullmann, D. M. (1999) Proc. Natl Acad. Sci. USA 96, 9932-9937.
25. Melyan, Z. & Kullmann, D. M. (1999) Soc. Neurosci. Abstr. 25, 1796.
26. Frerking, M., Petersen, C. C. H. & Nicoll, R. A. (1999) Proc. Natl. Acad. Sci. USA 96, 12917-12922.
27. Cunha, R. A., Constantino, M. D. & Ribeiro, J. A. (1997) Eur. J. Pharmacol. 323, 167-172.
28. Perkinton, M. S. & Sihra, T. S. (1999) Neuroscience 90, 1281-1292.